Brief: Jayex Technology Entered Into JV With Morph Clinical Services
29/01/2024 06:40
Jan 29 (Reuters) - Jayex Technology Ltd JTL.AX :
* ENTERED INTO JOINT VENTURE WITH MORPH CLINICAL SERVICES
LTD
* JV TO PROVIDE NEW CLINICALLY FOCUSED PACKAGE OF SERVICES
TO UK
BASED GENERAL PRACTICE CLINICS
* JV SYMBIA HEALTH LTD IS 50/50 JV BETWEEN CO & MORPH
CLINICAL
SERVICES
Source text for Eikon: ID:nASX1gMBdf
Further company coverage: JTL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jayex Technology
See all newsBrief: Jayex Technology Announces Voluntary Delisting From ASX
Brief: Jayex Technology Ltd Seeks Trading Halt
Brief: Jayex Technology Entered Into JV With Morph Clinical Services
Australia's Jayex Technology jumps on JV with UK-based company
Brief: Jayex Technology Announces Termination Of Binding Term Sheet Agreement Dated 31 January